WELLINGTON MANAGEMENT GROUP LLP
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$431,280
-$31,059 QoQ
Shares Held
179,700
-63.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 148 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority
Sole 0%
Shared 68%
None 32%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. LXRX ranks #188 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in LXRX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $431,280 | 179,700 | Shares | Defined | 2026-08-14 | |
| 2025-06-30 | $462,339 | 486,674 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $553,516 | 747,996 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,150,412 | 732,747 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,240,894 | 738,628 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,647,402 | 686,418 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $412,783 | 378,701 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $325,193 | 142,006 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $368,127 | 151,493 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $297,780 | 155,906 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $373,543 | 155,643 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $403,985 | 217,197 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $453,941 | 217,197 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $849,230 | 215,541 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||